AmphetamineDopamineRacloprideReceptors, Dopamine D2Dopamine AntagonistsAmphetaminesDopamine Plasma Membrane Transport ProteinsSalicylamidesCorpus StriatumReceptors, Dopamine D1Dopamine AgonistsCocaineReceptors, DopamineCarbon RadioisotopesReceptors, Dopamine D3Central Nervous System StimulantsDopamine AgentsDextroamphetamineDopamine Uptake InhibitorsSynapsesMethamphetamineAmphetamine-Related DisordersReceptors, Dopamine D5Nucleus AccumbensDopamine beta-HydroxylaseQuinpiroleN-Methyl-3,4-methylenedioxyamphetamineSubstance Abuse DetectionBehavior, AnimalMotor ActivityBenzazepinesStereotyped BehaviorRats, Sprague-DawleyNeostriatumApomorphineMicrodialysisHaloperidolSulpirideVentral Tegmental Area3,4-MethylenedioxyamphetamineNomifensineHomovanillic AcidCaudate Nucleusalpha-MethyltyrosineLevodopaDose-Response Relationship, DrugDopaminergic NeuronsTyrosine 3-MonooxygenaseRewardOxidopamineStreet DrugsGas Chromatography-Mass SpectrometrySubstantia NigraDesigner DrugsDopamine and cAMP-Regulated Phosphoprotein 32MesencephalonMethylphenidateSpiperoneAppetite DepressantsSerotoninNeuronsPutamenBiogenic MonoaminesConditioning, OperantBrainVesicular Monoamine Transport ProteinsReserpineAdrenergic Uptake InhibitorsFlupenthixolHallucinogensSelf AdministrationDrug InteractionsPrefrontal CortexErgolinesDihydroxyphenylalanineAdrenergic AgentsNorepinephrineHyperkinesisTyraminep-ChloroamphetamineCatalepsyRats, Long-EvansAnalysis of VarianceCocaine-Related DisordersBiogenic AminesBrain ChemistrySerotonin AgentsEnzyme Multiplied Immunoassay TechniqueForensic MedicineLocomotionDomperidonePargylineSubstance Withdrawal SyndromePsychoses, Substance-InducedMonoamine Oxidase InhibitorsTime FactorsSynaptosomesPhenethylaminesLimbic SystemLisuride